[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate

C22H32N6O3 — CID 162369134

IUPAC[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate
SMILESCCCNC(=O)O[C@H]1CC[C@@H](C2CC(NC(=O)Cc3ccc4nc(C)[nH]c4c3)NN2)C1
InChIInChI=1S/C22H32N6O3/c1-3-8-23-22(30)31-16-6-5-15(11-16)18-12-20(28-27-18)26-21(29)10-14-4-7-17-19(9-14)25-13(2)24-17/h4,7,9,15-16,18,20,27-28H,3,5-6,8,10-12H2,1-2H3,(H,23,30)(H,24,25)(H,26,29)/t15-,16+,18?,20?/m1/s1
InChIKeyGOMMWKKHAYGARW-NVOXVDHGSA-N
MW428.54 g/mol
LogP2.03
Rot. Bonds7

About [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate

[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate (PubChem CID 162369134) has the molecular formula C22H32N6O3 and a molecular weight of 428.54 g/mol. Its IUPAC name is [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate.

Molecular Properties

Compound Name[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate
PubChem CID162369134
Molecular FormulaC22H32N6O3
Molecular Weight428.54 g/mol
Exact Mass428.25
IUPAC Name[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate
SMILESCCCNC(=O)O[C@H]1CC[C@@H](C2CC(NC(=O)Cc3ccc4nc(C)[nH]c4c3)NN2)C1
InChIInChI=1S/C22H32N6O3/c1-3-8-23-22(30)31-16-6-5-15(11-16)18-12-20(28-27-18)26-21(29)10-14-4-7-17-19(9-14)25-13(2)24-17/h4,7,9,15-16,18,20,27-28H,3,5-6,8,10-12H2,1-2H3,(H,23,30)(H,24,25)(H,26,29)/t15-,16+,18?,20?/m1/s1
InChIKeyGOMMWKKHAYGARW-NVOXVDHGSA-N
XLogP2.03
TPSA120.17 Ų
H-Bond Donors5
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500428.54
LogP ≤ 52.03
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 106

Analyze [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate?
The IUPAC name of [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate (CID 162369134) is [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate.
What is the SMILES notation for [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate?
The canonical SMILES for [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate is CCCNC(=O)O[C@H]1CC[C@@H](C2CC(NC(=O)Cc3ccc4nc(C)[nH]c4c3)NN2)C1.
What is the InChIKey of [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate?
The InChIKey is GOMMWKKHAYGARW-NVOXVDHGSA-N. The full InChI is InChI=1S/C22H32N6O3/c1-3-8-23-22(30)31-16-6-5-15(11-16)18-12-20(28-27-18)26-21(29)10-14-4-7-17-19(9-14)25-13(2)24-17/h4,7,9,15-16,18,20,27-28H,3,5-6,8,10-12H2,1-2H3,(H,23,30)(H,24,25)(H,26,29)/t15-,16+,18?,20?/m1/s1.
What are the key properties of [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate?
[(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate has a molecular weight of 428.54 g/mol, XLogP of 2.03, 7 rotatable bonds, 5 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [(1S,3R)-3-[5-[[2-(2-methyl-3H-benzimidazol-5-yl)acetyl]amino]pyrazolidin-3-yl]cyclopentyl] N-propylcarbamate is sourced from PubChem (CID 162369134), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).